About NFATC2-interacting protein
NFATC2-interacting protein (NFATC2IP) is a protein
from Homo sapiens identified by UniProt accession
Q8NCF5, 419 residues long.
MolForge cross-references it against 0 known binders and
94 disease associations.
Target properties
| Protein name | NFATC2-interacting protein |
| UniProt accession | Q8NCF5 |
| Gene | NFATC2IP |
| Organism | Homo sapiens |
| Length | 419 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (94)
Diseases linked to this target (Open Targets).
- serum non-albumin protein measurement · score 0.14
- lymphocyte count · score 0.14
- hemoglobin measurement · score 0.10
- electrocardiography · score 0.09
- total blood protein measurement · score 0.07
- risk-taking behaviour · score 0.06
- isolated agammaglobulinemia · score 0.05
- severe combined immunodeficiency due to CTPS1 deficiency · score 0.05
- T-B+ severe combined immunodeficiency due to JAK3 deficiency · score 0.05
- severe combined immunodeficiency due to CARD11 deficiency · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NCF5-F1 | alphafold | PREDICTED | 65.18 | — |
Amino-acid sequence (419 residues)
MAEPVGKRGR WSGGSGAGRG GRGGWGGRGR RPRAQRSPSR GTLDVVSVDL VTDSDEEILE VATARGAADE VEVEPPEPPG PVASRDNSNS DSEGEDRRPA GPPREPVRRR RRLVLDPGEA PLVPVYSGKV KSSLRLIPDD LSLLKLYPPG DEEEAELADS SGLYHEGSPS PGSPWKTKLR TKDKEEKKKT EFLDLDNSPL SPPSPRTKSR THTRALKKLS EVNKRLQDLR SCLSPKPPQG QEQQGQEDEV VLVEGPTLPE TPRLFPLKIR CRADLVRLPL RMSEPLQSVV DHMATHLGVS PSRILLLFGE TELSPTATPR TLKLGVADII DCVVLTSSPE ATETSQQLQL RVQGKEKHQT LEVSLSRDSP LKTLMSHYEE AMGLSGRKLS FFFDGTKLSG RELPADLGME SGDLIEVWG
Explore NFATC2-interacting protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets